Overview
- WHO issued a medical alert for specific batches of Coldrif (Sresan), Respifresh TR (Rednex) and ReLife (Shape), warning of severe, potentially life‑threatening harm, with India reporting no exports of the flagged lots.
- Tamil Nadu permanently canceled Sresan Pharmaceuticals’ manufacturing licence, ordered the facility closed, and directed comprehensive inspections of other drug units statewide.
- The Enforcement Directorate searched seven Chennai locations linked to Sresan and senior Tamil Nadu drug control officials under the Prevention of Money Laundering Act.
- Official lab reports in Tamil Nadu and Madhya Pradesh found diethylene glycol at about 46–48.6% in Coldrif Batch SR‑13, far above the 0.1% limit, with at least 22 child deaths linked to the syrup.
- Madhya Pradesh police said an arrested paediatrician, Praveen Soni, admitted taking a 10% commission per Coldrif bottle prescribed, a claim his lawyer disputes.